Seo-Ho Cho1, Stephanie A Leonard2, Audrey Lyndon3, Elliott K Main4, Barbara Abrams5, Afshan B Hameed6,7, Suzan L Carmichael8,2. 1. Division of Neonatal and Developmental Medicine, Department of Pediatrics, Stanford Prevention Research Center, Stanford University School of Medicine, Stanford, California. 2. Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, California. 3. Rory Meyers College of Nursing, New York University, New York, New York. 4. California Maternal Quality Care Collaborative, Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, California. 5. Division of Epidemiology, University of California Berkeley School of Public Health, Berkeley, California. 6. Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of California Irvine School of Medicine, Irvine, California. 7. Division of Cardiology, Department of Medicine, University of California Irvine School of Medicine, Irvine, California. 8. Division of Neonatal and Developmental Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, California.
Abstract
OBJECTIVE: The aim of this study is to evaluate the contribution of pre-pregnancy obesity and overweight to peripartum cardiomyopathy. STUDY DESIGN: This population-based study used linked birth record and maternal hospital discharge data from live births in California during 2007 to 2012 (n = 2,548,380). All women who had a diagnosis of peripartum cardiomyopathy during the childbirth hospitalization or who were diagnosed with peripartum cardiomyopathy during a postpartum hospital readmission within 5 months of birth were identified as cases. Pre-pregnancy body mass index (BMI, kg/m2) was classified as normal weight (18.5-24.9), overweight (25.0-29.9), obesity class 1 (30.0-34.9), obesity class 2 (35.0-39.9), and obesity class 3 (≥40). Because of small numbers, we excluded women with underweight BMI, and in some analyses, we combined obesity classes into one group. Logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) expressing associations between BMI and peripartum cardiomyopathy, adjusted for maternal age, race/ethnicity, education, health care payer, parity, plurality, and comorbidities. RESULTS: The overall prevalence of peripartum cardiomyopathy during hospital admissions was 1.3 per 10,000 live births (n = 320). Unadjusted ORs were 1.32 (95% CI: 1.01-1.74) for women with overweight BMI and 2.03 (95% CI: 1.57-2.62) for women with obesity, compared with women with normal pre-pregnancy BMI. Adjusted ORs were 1.26 (95% CI: 0.95-1.66) for overweight women and 1.38 (95% CI: 1.04-1.84) for women with obesity. The ORs suggested a dose-response relationship with increasing levels of obesity, but the 95% CIs for the specific classes of obesity included 1.00. CONCLUSION: Pre-pregnancy obesity was associated with an increased risk of peripartum cardiomyopathy. These findings underscore the importance of BMI during pregnancy. There is a need to recognize the increased risk of peripartum cardiomyopathy in women with high BMI, especially in the late postpartum period. KEY POINTS: · Pre-pregnancy obesity affects maternal health.. · Effects may extend to peripartum cardiomyopathy.. · The risk includes peripartum cardiomyopathy that emerges postpartum.. Thieme. All rights reserved.
OBJECTIVE: The aim of this study is to evaluate the contribution of pre-pregnancy obesity and overweight to peripartum cardiomyopathy. STUDY DESIGN: This population-based study used linked birth record and maternal hospital discharge data from live births in California during 2007 to 2012 (n = 2,548,380). All women who had a diagnosis of peripartum cardiomyopathy during the childbirth hospitalization or who were diagnosed with peripartum cardiomyopathy during a postpartum hospital readmission within 5 months of birth were identified as cases. Pre-pregnancy body mass index (BMI, kg/m2) was classified as normal weight (18.5-24.9), overweight (25.0-29.9), obesity class 1 (30.0-34.9), obesity class 2 (35.0-39.9), and obesity class 3 (≥40). Because of small numbers, we excluded women with underweight BMI, and in some analyses, we combined obesity classes into one group. Logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) expressing associations between BMI and peripartum cardiomyopathy, adjusted for maternal age, race/ethnicity, education, health care payer, parity, plurality, and comorbidities. RESULTS: The overall prevalence of peripartum cardiomyopathy during hospital admissions was 1.3 per 10,000 live births (n = 320). Unadjusted ORs were 1.32 (95% CI: 1.01-1.74) for women with overweight BMI and 2.03 (95% CI: 1.57-2.62) for women with obesity, compared with women with normal pre-pregnancy BMI. Adjusted ORs were 1.26 (95% CI: 0.95-1.66) for overweight women and 1.38 (95% CI: 1.04-1.84) for women with obesity. The ORs suggested a dose-response relationship with increasing levels of obesity, but the 95% CIs for the specific classes of obesity included 1.00. CONCLUSION: Pre-pregnancy obesity was associated with an increased risk of peripartum cardiomyopathy. These findings underscore the importance of BMI during pregnancy. There is a need to recognize the increased risk of peripartum cardiomyopathy in women with high BMI, especially in the late postpartum period. KEY POINTS: · Pre-pregnancy obesity affects maternal health.. · Effects may extend to peripartum cardiomyopathy.. · The risk includes peripartum cardiomyopathy that emerges postpartum.. Thieme. All rights reserved.
Authors: Mona T Lydon-Rochelle; Victoria L Holt; Vicky Cárdenas; Jennifer C Nelson; Thomas R Easterling; Carolyn Gardella; William M Callaghan Journal: Am J Obstet Gynecol Date: 2005-07 Impact factor: 8.661
Authors: Tendoh Timoh; Michelle E Bloom; Robert R Siegel; Gabriel Wagman; Gregg M Lanier; Timothy J Vittorio Journal: Obes Res Clin Pract Date: 2012 Jul-Sep Impact factor: 2.288
Authors: Karen Sliwa; Mark C Petrie; Denise Hilfiker-Kleiner; Alexandre Mebazaa; Alice Jackson; Mark R Johnson; Peter van der Meer; Amam Mbakwem; Johann Bauersachs Journal: Eur J Heart Fail Date: 2018-03-26 Impact factor: 15.534
Authors: Dhaval Kolte; Sahil Khera; Wilbert S Aronow; Chandrasekar Palaniswamy; Marjan Mujib; Chul Ahn; Diwakar Jain; Alan Gass; Ali Ahmed; Julio A Panza; Gregg C Fonarow Journal: J Am Heart Assoc Date: 2014-06-04 Impact factor: 5.501
Authors: Iwan Cahyo Santosa Putra; Christian Bobby Irianto; Wilson Matthew Raffaello; Leonardo Paskah Suciadi; Hawani Sasmaya Prameswari Journal: Indian Heart J Date: 2022-04-28
Authors: Magnus C Johansson; Anders Barasa; Carmen Basic; Gunnar Nyberg; Maria Schaufelberger Journal: Clin Physiol Funct Imaging Date: 2020-11-06 Impact factor: 2.273